Appointment news
September 6, 2022
Kauko Väinämö has been appointed as CEO of Ginolis Oy from September 1, 2022. Kauko has more than 30 years of solid knowledge in strategic leadership, having
Kauko Väinämö has been appointed as CEO of Ginolis Oy from September 1, 2022. Kauko has more than 30 years of solid knowledge in strategic leadership, having
A suite of Ginolis LFDA assembly solutions helps Abingdon Health to produce tens of millions of rapid tests per year. The combination of Abingdon Health’s
A global pandemic presents many challenges for diagnostic device manufacturers, especially those dependent on traditional manufacturing processes that are not conducive to the social distancing
by Michael Severino, Ginolis Sales Manager, U.S. East Coast A global pandemic presents many challenges for diagnostic device manufacturers, especially those dependent on traditional manufacturing
Ginolis Ltd. and CELLINK AB have entered into an agreement where CELLINK acquires 100 per cent of Ginolis shares. With this acquisition, Ginolis will be
Bureau Veritas has certified that the management system of Ginolis Ltd has been audited and found to be following the ISO 9001:2015 standard requirements. The
© Ginolis Oy | Privacy policy
